Cartesian Therapeutics, Inc. (RNAC) Ownership

$10.19

south_east
-$0.15 (-1.45%)
Day's range
$9.87
Day's range
$10.48

Cartesian Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 2.16 M $22.03 M   -7.64% 8.30%
BLACKROCK, INC. 11/12/2025 649.34 K $6.64 M   -0.69% 2.50%
SIREN, L.L.C. 11/13/2025 563.27 K $5.76 M   0.00% 2.17%
VANGUARD GROUP INC 11/07/2025 520.72 K $5.32 M   4.91% 2.00%
BIOIMPACT CAPITAL LLC 11/14/2025 380.00 K $3.88 M   -44.61% 1.46%
ERSTE ASSET MANAGEMENT GMBH 11/12/2025 260.01 K $2.56 M   0.00% 1.00%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 241.83 K $2.47 M   10.46% 0.93%
683 CAPITAL MANAGEMENT, LLC 11/14/2025 230.00 K $2.35 M   5.02% 0.89%
STATE STREET CORP 11/14/2025 197.67 K $2.02 M   1.75% 0.76%
NORTHERN TRUST CORP 11/14/2025 91.29 K $932.97 K   10.06% 0.35%
GSA CAPITAL PARTNERS LLP 11/07/2025 86.10 K $880.00 K   106.95% 0.33%
MARSHALL WACE, LLP 11/13/2025 84.81 K $866.72 K   2.63% 0.33%
CITADEL ADVISORS LLC 11/14/2025 70.52 K $720.76 K   -41.65% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 67.60 K $690.87 K   45.38% 0.26%
ROYAL BANK OF CANADA 11/14/2025 36.22 K $370.00 K   97.93% 0.14%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 30.00 K $306.61 K   -27.39% 0.12%
FREESTONE CAPITAL HOLDINGS, LLC 11/12/2025 25.92 K $264.91 K   0.00% 0.10%
MILLENNIUM MANAGEMENT LLC 11/14/2025 25.36 K $259.15 K   100.00% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 25.00 K $255.50 K   100.00% 0.10%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 24.90 K $254.43 K   -0.03% 0.10%
NUVEEN, LLC 11/12/2025 24.50 K $250.36 K   0.00% 0.09%
BANK OF NEW YORK MELLON CORP 11/03/2025 24.19 K $247.23 K   -3.16% 0.09%
IKARIAN CAPITAL, LLC 11/14/2025 22.17 K $226.54 K   0.00% 0.09%
TWIN FOCUS CAPITAL PARTNERS, LLC 11/12/2025 19.50 K $199.29 K   2.63% 0.08%
MORGAN STANLEY 11/14/2025 18.97 K $193.91 K   -35.05% 0.07%
BARCLAYS PLC 11/12/2025 17.84 K $182.35 K   -41.84% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 16.60 K $169.65 K   100.00% 0.06%
CITADEL ADVISORS LLC 11/14/2025 16.00 K $163.52 K   20.30% 0.06%
BANK OF AMERICA CORP /DE/ 11/14/2025 14.07 K $143.79 K   0.98% 0.05%
RHUMBLINE ADVISERS 11/06/2025 13.13 K $134.22 K   -0.28% 0.05%
ALLIANCEBERNSTEIN L.P. 11/14/2025 12.77 K $130.46 K   7.31% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 12.33 K $126.01 K   6.57% 0.05%
MILLER FINANCIAL SERVICES LLC 11/13/2025 11.64 K $118.99 K   0.00% 0.04%
VIRTUS INVESTMENT ADVISERS, INC. 11/14/2025 11.11 K $113.57 K   21.01% 0.04%
UBS GROUP AG 11/13/2025 9.95 K $101.67 K   -24.67% 0.04%
WELLS FARGO & COMPANY/MN 11/13/2025 7.88 K $80.57 K   35.16% 0.03%
DEUTSCHE BANK AG\ 11/13/2025 7.42 K $75.87 K   0.00% 0.03%
QUEST PARTNERS LLC 11/03/2025 6.92 K $70.76 K   64.58% 0.03%
JPMORGAN CHASE & CO 11/26/2025 6.12 K $62.59 K   0.72% 0.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 4.88 K $49.83 K   -3.56% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 11/10/2025 4.56 K $46.58 K   -12.56% 0.02%
NEW YORK STATE COMMON RETIREMENT FUND 11/03/2025 3.90 K $39.88 K   0.00% 0.02%
POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 11/12/2025 2.94 K $30.04 K   0.00% 0.01%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 2.24 K $22.89 K   62.55% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 1.31 K $13.41 K   -56.05% 0.01%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 11/03/2025 1.01 K $10.27 K   -78.70% 0.00%
ALERUS FINANCIAL NA 11/10/2025 1.00 K $10.22 K   0.00% 0.00%
LEGAL & GENERAL GROUP PLC 11/13/2025 938 $9.59 K   0.00% 0.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 11/14/2025 767 $7.84 K   0.13% 0.00%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 767 $7.84 K   1,294.55% 0.00%

Cartesian Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 74 institutional investors and hedge funds held shares of Cartesian Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 2.16 M

BlackRock, Inc.: 649,341

Siren, L.L.C.: 563,272

VANGUARD GROUP INC: 520,722

BioImpact Capital LLC: 380,000

Erste Asset Management GmbH: 260,011

22.97% of Cartesian Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 6.45 M shares in the last 24 months. This purchase volume represents approximately $65.71 M in transactions.